回转时钟:人类抗衰老疗法的新兴药理策略
Charlotte Delrue1, Reinhart Speeckaert2, Marijn M Speeckaert1,3
1Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
International journal of molecular sciences
|October 16, 2025
概括
本综述探讨了针对衰老特征的药物治疗干预措施,以延长健康寿命并减少与年龄相关的疾病. 它将老化剂和NAD+前体等策略分类,讨论它们的潜力和临床挑战.
科学领域:
- 老年学和衰老生物学
- 药理学 药理学是指药理学的学科.
- 生物医学科学 生物医学科学
背景情况:
- 衰老是一个复杂的过程,涉及生理衰退和增加疾病风险.
- 确定了9个关键的衰老特征,包括基因组不稳定性和细胞衰老.
- 这些特征为开发改善健康范围的干预提供了一个框架.
研究的目的:
- 审查针对衰老特征的现有和新兴药物治疗干预措施.
- 将这些干预措施分类并评估它们的机制,有效性和临床潜力.
- 检查当前的临床环境,正在进行的试验和老年治疗开发中的挑战.
主要方法:
- 对抗衰老的药物治疗策略的文献综述.
- 将干预措施分为以下类别:老化剂,老态药物,NAD+前体,mTOR抑制剂和代谢修饰剂.
- 分析临床前证据,临床试验数据和发现的障碍.
主要成果:
- 药物治疗策略根据其针对衰老特征进行分类.
- 对各种干预措施的临床前和临床疗效证据进行了审查.
- 确定了包括生物标志物识别,安全和监管障碍在内的关键挑战.
结论:
- 通过一种以机制为重点的方法准衰老生物学对老年治疗有希望.
- 开发改善健康的干预措施需要解决安全和监管方面的挑战.
- 未来的研究应该集中在治疗衰老干预的集体,基于机制的策略上.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Aging
587
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
587
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228


